UsAgainstAlzheimer's
UsAgainstAlzheimer's is a 501(c)(3) nonprofit that runs digital brain-health platforms (BrainGuide, A-LIST, NADEX), convenes major Alzheimer's coalitions and consortiums, and advocates for prevention, early detection, and treatment access, with a focus on health equity for women and communities of color.
- Company typePrivate
- Founded2010
- HeadquartersWashington, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What UsAgainstAlzheimer's does
UsAgainstAlzheimer's (UsA2) is a 501(c)(3) nonprofit founded in 2010 and headquartered in Washington, DC, focused on catalyzing change in the Alzheimer's and dementia health ecosystem through prevention, early detection, and access to treatments, with a particular emphasis on health equity for women and communities of color. The organization operates a portfolio of digital platforms, including BrainGuide / MyBrainGuide (a confidential memory questionnaire available online or by phone in English and Spanish, with tailored education and a clinical trial connector), the A-LIST patient- and caregiver-led research network, the AD-PACE engagement initiative, the Brain Health Academy for healthcare professionals (with CME/CE credits), and the National Alzheimer's Disease Index (NADEX), a Medicare-data analytics tool for health-equity research. MyBrainGuide's 2026 expansion integrates Synapticure and Isaac Health for direct specialist access across all 50 states.
Its business model is donor- and member-supported: it generates revenue through tax-deductible individual donations, three membership tiers ($25/year Member, $100/year Ally, $10/month Champion), corporate sponsorships (Biogen, Bristol Myers Squibb, Eisai, Eli Lilly, Johnson & Johnson as Summit sponsors), and a CDC cooperative agreement supporting the Center for Brain Health Equity. All core programs are provided free to the public. The organization also convenes a portfolio of large cross-sector consortiums — the LEAD Coalition (now 280+ member organizations, 3M+ individuals reachable), the Global CEO Initiative on Alzheimer's Disease (CEOi), the Davos Alzheimer's Collaborative, and the Global Alliance on Women's Brain Health — that constitute its primary structural and competitive assets. In 2026, the organization is undergoing a leadership transition: Russ Paulsen was named President and COO in February 2026, followed by Co-Founder and Chairman George Vradenburg's announced transition in April 2026.
UsAgainstAlzheimer's firmographics
Firmographics- Name
- UsAgainstAlzheimer's
- Legal name
- UsAgainstAlzheimer's
- Website
- https://usagainstalzheimers.org
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- UsAgainstAlzheimer's is a 501(c)(3) nonprofit that runs digital brain-health platforms (BrainGuide, A-LIST, NADEX), convenes major Alzheimer's coalitions and consortiums, and advocates for prevention, early detection, and treatment access, with a focus on health equity for women and communities of color.
- Ownership category
- akta.pro rank
UsAgainstAlzheimer's industry classification
Industry- Product category
- Alzheimer's Advocacy and Brain Health Nonprofit Services
- NAICS
- Services for the Elderly and Persons with Disabilities (624120), Other Individual and Family Services (624190)
- SIC
- Services-Home Health Care Services (8082)
- akta.pro primary industry
- Dementia/Alzheimer’s Care Management & Behavioral Support (HLADALAF)
- akta.pro secondary industries
- Memory Care Care Management & Navigation (Dementia Care Coordination) (HLADACAJ), Dementia Care Coordination & Care Planning (HSABAEAJ), Cognitive Stimulation & Reminiscence Therapy (Non-Clinical) (HSABAEAH)
Keywords
Where UsAgainstAlzheimer's is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
UsAgainstAlzheimer's business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Technology or R&D, Others
Revenue model
- Donations and Membership Program: The organization generates revenue through tax-deductible donations from individuals, membership program fees (starting at $25/year for Member level, $100/year for Ally level, and $10/month for Champion level), and other giving mechanisms including matching gifts, stocks and securities, donor advised funds, and legacy gifts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Annual | Free membership tier with basic benefits |
| Subscription | Annual | Mid-tier membership with exclusive events |
| Subscription | Monthly | Premium monthly membership with full access |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels10 records
UsAgainstAlzheimer's product offering
Product offeringCore offering
UsAgainstAlzheimer's is a 501(c)(3) nonprofit that delivers free brain health education, early detection tools, patient and caregiver engagement programs, and policy advocacy to stop Alzheimer's. Its flagship offering is BrainGuide/MyBrainGuide, a confidential memory questionnaire platform available online and by phone in English and Spanish that provides tailored brain health resources and connects users to dementia specialists. The organization also operates the A-LIST research network, Brain Health Academy courses for healthcare professionals, the National Alzheimer's Disease Index data tool, and convenes major coalitions including the LEAD Coalition and Global CEO Initiative on Alzheimer's Disease.
Product overview
UsAgainstAlzheimer's is an advocacy organization offering a portfolio of digital products and programs centered on prevention, early detection, and access to treatments for Alzheimer's disease. The core digital product is BrainGuide/MyBrainGuide, a first-of-its-kind brain health platform featuring a confidential memory questionnaire available over the phone or online in English or Spanish, with tailored education and resources. The platform connects users to dementia specialists through integrations with Synapticure and Isaac Health, and includes a clinical trial connector. Complementary programs include the A-LIST patient/caregiver research network, AD-PACE engagement initiative, and Brain Health Academy educational courses. Major convened initiatives include the Global CEO Initiative on Alzheimer's Disease (CEOi), LEAD Coalition of over 90 organizations, and Davos Alzheimer's Collaborative. The Center for Brain Health Equity and Advancing Women's Brain Health Initiative address health disparities affecting women and people of color. Additional offerings include the BrainStorm podcast, National Alzheimer's Summit, Women's Leadership Council, National Alzheimer's Disease Index data tool, and Brain Health Equity Nurse Fellowship.
Differentiator
Problem solved
Functional benefit
Brands
- BrainGuide: A first-of-its-kind platform to help people understand and manage their brain health, featuring a confidential memory questionnaire available in English and Spanish.
- BrainStorm
- Be Brain Powerful
- Global Alzheimer's Platform Foundation
- LEAD Coalition
- Davos Alzheimer's Collaborative
Products and services
- BrainGuide
- MyBrainGuide
- A-LIST
- Brain Health Academy
- National Alzheimer's Disease Index (NADEX)
- Center for Brain Health Equity
- Brain Health Equity Nurse Fellowship
- BrainStorm Podcast
- National Alzheimer's Summit
- Global CEO Initiative on Alzheimer's Disease (CEOi)
- LEAD Coalition (Leaders Engaged on Alzheimer's Disease)
- Davos Alzheimer's Collaborative
- Advancing Women's Brain Health Initiative
Quantifiable outcome
- Reached 700,000 Black and Latino individuals with tailored brain health messaging in year one of Center for Brain Health Equity
- +4 more outcomes
Companies that use UsAgainstAlzheimer's
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
UsAgainstAlzheimer's technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature5 records
UsAgainstAlzheimer's partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- Centers for Disease Control and Prevention (CDC)coreFederal agency partner through CDC's Healthy Brain Initiative cooperative agreement enabling the Center for Brain Health Equity work. CDC provides funding and collaboration for brain health public health strategies.
- National Association of Hispanic Nurses (NAHN)coreKey partner in Center for Brain Health Equity collaboration, working to educate and mobilize minority serving health providers and promote culturally tailored brain health messaging.
- National Black Nurses Association (NBNA)coreKey partner in Center for Brain Health Equity collaboration, working on brain health equity initiatives and nurse fellowship programs.
- Alzheimer's Los AngelescorePartner in Center for Brain Health Equity collaboration, contributing to culturally tailored brain health resources and education.
- SynapticurecoreVirtual neurology care practice collaboration with MyBrainGuide to help individuals and families connect more quickly with dementia specialists. Provides rapid access to dementia assessment, diagnosis, and treatment planning across all 50 states.
- Isaac HealthcoreVirtual-first memory and brain health clinic collaboration with MyBrainGuide providing rapid access to cognitive specialists and personalized care across all 50 states.
- Mayo ClinicminorResearch partner on A-LIST, collaborating to study lucid episodes among individuals with dementia.
- Dana FoundationminorPartner for Brain Health Awareness Week, collaborating on brain health awareness initiatives.
- Global Alzheimer's Platform (GAP) FoundationcoreIncubated initiative building the first global trial-ready platform for Alzheimer's drug development to reduce time, cost, and risk of bringing innovative medicines to market.
- Davos Alzheimer's CollaborativecoreGlobal initiative led by CEOi and World Economic Forum developing a global cohort to identify treatment targets, clinical trial platform, and healthcare system readiness.
- LEAD CoalitioncoreLeaders Engaged on Alzheimer's Disease - the largest nationwide coalition of Alzheimer's organizations with over 90 member organizations reaching more than 3 million individuals. UsAgainstAlzheimer's created and convenes this coalition.
- Global CEO Initiative on Alzheimer's Disease (CEOi)coreConvened consortium bringing together top private-sector leaders to collaborate with government and researchers to overcome barriers to Alzheimer's treatments.
- United for CuresminorCollaborative network of patient advocacy organizations dedicated to protecting and strengthening federal medical research funding.
- Home InsteadminorResearch partner supporting A-LIST initiative and Alzheimer's caregiving research.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
UsAgainstAlzheimer's competitors and assessment
Company assessmentDirect peers
- BrightFocus Foundation: Nonprofit funding research on Alzheimer's, macular degeneration, and glaucoma, plus public education. Comparable to UsA2 as a disease-focused nonprofit combining research grants with public brain/eye health education.
- Alzheimer's Association: The largest U.S. Alzheimer's disease nonprofit; runs the 24/7 Helpline, care and support programs, research funding, and federal advocacy. Directly comparable to UsAgainstAlzheimer's as a national Alzheimer's advocacy, research-funding, and care-support organization, but with much larger reach and budget.
- Alzheimer's Drug Discovery Foundation: Nonprofit that funds drug discovery and translational research for Alzheimer's and related dementias. Comparable to UsA2 in mission focus on accelerating treatments, but with a more direct biomedical-research-grant-making model rather than advocacy/convening.
- Cure Alzheimer's Fund: Nonprofit that funds high-potential Alzheimer's research with a venture-philanthropy approach. Comparable to UsA2's research-funding advocacy function, though smaller and more narrowly focused on biomedical research grants.
Emerging players
- Synapticure: Virtual neurology care practice providing dementia assessment, diagnosis, and treatment across all 50 states. Comparable to UsA2 as a MyBrainGuide integration partner addressing the same patient journey; an emerging specialty care delivery player in the dementia space.
- Davos Alzheimer's Collaborative: Global initiative co-launched by UsA2 (via CEOi) and the World Economic Forum building a global cohort, clinical trial platform, and healthcare system readiness for Alzheimer's. Comparable as a convening entity in the same ecosystem, partially incubated and co-led by UsA2.
Regional players
- Alzheimer's Research UK: U.K.-based dementia research charity with global research funding and public-facing brain health campaigns. Comparable in mission to UsA2's advocacy and research-funding model, but primarily serving the U.K. and Europe rather than the U.S.
Broad incumbents
- Mayo Clinic: Large academic medical center with significant Alzheimer's research, clinical trials, and the Alzheimer's Disease Research Center network. Comparable to UsA2 as a clinical-research partner on A-LIST and as a major player in the same patient/caregiver engagement ecosystem.
- National Institute on Aging (NIA): Lead U.S. federal agency for Alzheimer's and aging research, distributing the majority of federal dementia research dollars UsA2 helped scale to $3.1B in FY2021. Comparable as the primary research-funding incumbent whose budget UsA2's advocacy directly influences.
Others
- Home Instead: Largest in-home personal care network focused on aging seniors, including Alzheimer's and dementia care. Comparable to UsA2 through the Home Instead board presence (Paul Hogan, co-founder) and A-LIST caregiving research partnership; represents the in-home caregiver delivery side of the same mission.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
UsAgainstAlzheimer's social profiles
Digital presenceUsAgainstAlzheimer's financial estimates
Financial estimateRevenue estimate
Valuation estimate
UsAgainstAlzheimer's leadership team
Management profileNumber of profiles
Profiles16 records
UsAgainstAlzheimer's funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UsAgainstAlzheimer's M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UsAgainstAlzheimer's
What does UsAgainstAlzheimer's do?
UsAgainstAlzheimer's is a 501(c)(3) nonprofit that delivers free brain health education, early detection tools, patient and caregiver engagement programs, and policy advocacy to stop Alzheimer's. Its flagship offering is BrainGuide/MyBrainGuide, a confidential memory questionnaire platform available online and by phone in English and Spanish that provides tailored brain health resources and connects users to dementia specialists. The organization also operates the A-LIST research network, Brain Health Academy courses for healthcare professionals, the National Alzheimer's Disease Index data tool, and convenes major coalitions including the LEAD Coalition and Global CEO Initiative on Alzheimer's Disease.
Is UsAgainstAlzheimer's a public or private company?
UsAgainstAlzheimer's is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was UsAgainstAlzheimer's founded?
UsAgainstAlzheimer's was founded in 2010. It employs 11 to 50 people.
Where is UsAgainstAlzheimer's based?
UsAgainstAlzheimer's is headquartered in Washington, United States, in the North America region.
How does UsAgainstAlzheimer's make money?
One revenue line is on record: donations and Membership Program.
Who are UsAgainstAlzheimer's's main competitors?
Direct peers on record are BrightFocus Foundation, Alzheimer's Association, Alzheimer's Drug Discovery Foundation and Cure Alzheimer's Fund. Emerging players are Synapticure and Davos Alzheimer's Collaborative. Alzheimer's Research UK is listed as a regional player. Broad incumbents are Mayo Clinic and National Institute on Aging (NIA). Home Instead is listed as an others.
Does UsAgainstAlzheimer's have an API?
No public API is recorded for UsAgainstAlzheimer's.
What industry is UsAgainstAlzheimer's in?
UsAgainstAlzheimer's's product category is Alzheimer's Advocacy and Brain Health Nonprofit Services. Its primary akta.pro industry code is HLADALAF, Dementia/Alzheimer’s Care Management & Behavioral Support, with a secondary code of HLADACAJ, Memory Care Care Management & Navigation (Dementia Care Coordination). Its NAICS code is 624120 and its SIC code is 8082.